BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17128453)

  • 1. Gene symbol: PANK2. Disease: pantothenate kinase-associated neurodegeneration (PKAN).
    Westaway SK; Ching KH; Levinson B; Gitschier J; Hayflick SJ
    Hum Genet; 2006 Jul; 119(6):672. PubMed ID: 17128453
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene symbol: PANK2. Disease: pantothenate kinase-associated neurodegeneration (PKAN).
    Westaway SK; Ching KH; Levinson B; Gitschier J; Hayflick SJ
    Hum Genet; 2006 Jul; 119(6):671-2. PubMed ID: 17128452
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene symbol: PANK2. Disease: pantothenate kinase-associated neurodegeneration (PKAN).
    Westaway SK; Ching KH; Levinson B; Gitschier J; Hayflick SJ
    Hum Genet; 2006 Jul; 119(6):673. PubMed ID: 17128458
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene symbol: PANK2. Disease: Pantothenate kinase associated neurodegeneration (PKAN).
    Wieczorek SW; Epplen JT
    Hum Genet; 2005 May; 116(6):545. PubMed ID: 15991335
    [No Abstract]   [Full Text] [Related]  

  • 5. Pantothenate kinase-associated neurodegeneration (PKAN): molecular confirmation of a Turkish patient with a rare frameshift mutation in the coding region of the PANK2 gene.
    Cangül H; Ozdemir O; Yakut T; Okan M; Morgan NV; Baytan B; Kurian MA; Spiegel R; Maher ER
    Turk J Pediatr; 2009; 51(2):161-5. PubMed ID: 19480328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene symbol: PANK2. Disease: Pantothenate kinase associated neurodegeneration (PKAN).
    Wieczorek S; Epplen JT
    Hum Genet; 2005 May; 116(6):535. PubMed ID: 15991305
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene symbol: PANK2. Disease: pantothenate kinase-associated neurodegeneration (PKAN).
    Westaway SK; Ching KH; Levinson B; Gitschier J; Hayflick SJ
    Hum Genet; 2006 Jul; 119(6):679. PubMed ID: 17128480
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene symbol: PANK2. Disease: pantothenate kinase-associated neurodegeneration (PKAN).
    Westaway SK; Robinson SW; Hayflick SJ; Richards S
    Hum Genet; 2006 Jul; 119(6):679. PubMed ID: 17128481
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene symbol: PANK2. Disease: pantothenate kinase-associated neurodegeneration (PKAN).
    Westaway SK; Ching KH; Levinson B; Gitschier J; Hayflick SJ
    Hum Genet; 2006 Jul; 119(6):678. PubMed ID: 17128476
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene symbol: PANK2. Disease: pantothenate kinase-associated neurodegeneration (PKAN).
    Westaway SK; Ching KH; Levinson B; Gitschier JG; Hayflick SJ
    Hum Genet; 2006 Jul; 119(6):677. PubMed ID: 17128475
    [No Abstract]   [Full Text] [Related]  

  • 11. Pantothenate-kinase associated neurodegeneration (PKAN) "eye of the tiger" sign.
    Renaud DL; Kotagal S
    Pediatr Neurol; 2007 Jan; 36(1):70-1. PubMed ID: 17162204
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel mutation in the PANK2 gene leads to pantothenate kinase-associated neurodegeneration in a Pakistani family.
    Saleheen D; Ali T; Aly Z; Khealani B; Frossard PM
    Pediatr Neurol; 2007 Oct; 37(4):296-8. PubMed ID: 17903678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pantothenate kinase-associated neurodegeneration: insights from a Drosophila model.
    Wu Z; Li C; Lv S; Zhou B
    Hum Mol Genet; 2009 Oct; 18(19):3659-72. PubMed ID: 19602483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the pantothenate kinase gene PANK2 are not associated with Parkinson disease.
    Klopstock T; Elstner M; Lücking CB; Müller-Myhsok B; Gasser T; Botz E; Lichtner P; Hörtnagel K
    Neurosci Lett; 2005 May; 379(3):195-8. PubMed ID: 15843062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic, clinical, and imaging characterization of one patient with late-onset, slowly progressive, pantothenate kinase-associated neurodegeneration.
    Antonini A; Goldwurm S; Benti R; Prokisch H; Ebhardt M; Cilia R; Zini M; Righini A; Cossu G; Pezzoli G
    Mov Disord; 2006 Mar; 21(3):417-8. PubMed ID: 16267847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel PANK2 gene mutation: clinical and molecular characteristics of patients short communication.
    Kazek B; Jamroz E; Gencik M; Jezela Stanek A; Marszal E; Wojaczynska-Stanek K
    J Child Neurol; 2007 Nov; 22(11):1256-9. PubMed ID: 18006953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathologic findings in an aged albino gorilla.
    Márquez M; Serafin A; Fernández-Bellon H; Serrat S; Ferrer-Admetlla A; Bertranpetit J; Ferrer I; Pumarola M
    Vet Pathol; 2008 Jul; 45(4):531-7. PubMed ID: 18587101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic heterogeneity in patients with pantothenate kinase-associated neurodegeneration and classic magnetic resonance imaging eye-of-the-tiger pattern.
    Valentino P; Annesi G; Cirò Candiano IC; Annesi F; Civitelli D; Tarantino P; Naso F; Spadafora P; Carrideo S; De Marco EV; Consoli D; Zappia M; Gambardella A; Quattrone A
    Mov Disord; 2006 Feb; 21(2):252-4. PubMed ID: 16149094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
    Thomas M; Hayflick SJ; Jankovic J
    Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical properties of human pantothenate kinase 2 isoforms and mutations linked to pantothenate kinase-associated neurodegeneration.
    Zhang YM; Rock CO; Jackowski S
    J Biol Chem; 2006 Jan; 281(1):107-14. PubMed ID: 16272150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.